Gene: ANKRD34B
Official Full Name: ankyrin repeat domain 34Bprovided by HGNC
Gene Summary: Predicted to be located in cytoplasm and nucleus. Predicted to be active in pi-body. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19840 | ANKRD34B Knockout cell line (HEK293) | Human | ANKRD34B | 1:3~1:6 | Negative | Online Inquiry |
ANKRD34B Gene Knockout Cell Lines are genetically modified human cell lines featuring targeted disruptions in the ANKRD34B gene. Through the application of CRISPR-Cas9 technology, these cell lines have been specifically developed to elucidate the biological functions of the ANKRD34B gene, which is implicated in various cellular processes such as proliferation, differentiation, and gene expression regulation. This innovative product allows researchers to explore the gene's role in health and disease more comprehensively, facilitating the dissection of molecular pathways influenced by ANKRD34B.
The primary function of these knockout cell lines is to serve as model systems for functional genomics studies. By creating a loss-of-function scenario for the ANKRD34B gene, researchers can assess how the absence of this gene affects cellular behavior through a variety of assays, including cell viability, migration, and reporter gene activity. The insights gained from these studies are pivotal for understanding the mechanisms by which ANKRD34B contributes to diseases such as cancer and neurological disorders.
In terms of scientific importance, the ANKRD34B Gene Knockout Cell Lines are invaluable for academic research and clinical applications. They enable a detailed investigation of gene function and the identification of potential therapeutic targets, providing a foundation for drug discovery and development processes. Researchers utilizing these cell lines can enhance their understanding of gene interactions, paving the way for new interventions in disease management.
A key advantage of the ANKRD34B Gene Knockout Cell Lines is the precision and reliability afforded by CRISPR technology, which allows for targeted gene editing with minimal off-target effects. Compared to traditional knockout techniques, such as homologous recombination methods, CRISPR-based knockouts offer a more efficient and streamlined approach for generating genetically modified cell lines. Additionally, these cell lines come with extensive characterizations that ensure reproducibility and validity in research settings.
For researchers and clinicians alike, the value of the ANKRD34B Gene Knockout Cell Lines lies in their ability to provide robust, scalable models for studying important biological questions. They facilitate the acceleration of discovery in molecular genetics and offer cutting-edge solutions to contemporary research challenges.
Our company is committed to advancing scientific research by providing high-quality, validated biological products that empower researchers worldwide. With a strong foundation in genomics and cell biology, we are dedicated to enhancing the toolkit available for cellular analysis and therapeutic exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.